tirzepatide fasting Intermittent on Tirzepatide: Safety & Effectiveness The promise of tirzepatide: A

This helps you avoid confusion the following week

While tirzepatide (sold as Mounjaro and Zepbound ) has dual action on both GLP-1 and GIP receptors and may be more effective for insulin-resistant patients, some individuals still need additional metabolic support

However, both medications can independently affect the gastrointestinal system , which warrants consideration

For healthcare leaders, biotech innovators, and strategy folks: this signals that the value proposition for GLP-1 therapies isnt solely weight loss or glycaemic control its anti-inflammation opens new therapeutic categories, pricing/benefit models, and organisational partnerships (endocrinology + immunology, metabolism + organ disease)